With 15 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $16.85B. The average expense ratio is 0.76%. Biotech ETFs can be found in the following asset classes:
The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $8.15B in assets. In the last trailing year, the best performing Biotech ETF was the PBE at 13.21%. The most-recent ETF launched in the Biotech space was the Loncar China BioPharma ETF CHNA in 08/14/18.